Advipro, a trusted provider of consultancy and project support in the life sciences sector, is making a strategic leap forward. As of May 2025, the company will operate under a new name: Normec Advipro. This rebrand signifies a closer alignment with the Normec Group, a leading player in Testing, Inspection, Certification & Compliance (TICC).
Pivot Park and QuestPair: Smart labs, strong starts
Throughout 2024, the Pivot Incubator team worked hard to ensure that the laboratories were fully equipped, allowing future startups to begin immediately. We recognised that setting up a well-equipped lab can be a significant challenge for emerging businesses, which is why we prioritised providing turnkey facilities. To achieve this, we partnered with expert organisations such as QuestPair.
Supporting talent through the Pedro Hermkens stipend
At Pivot Park, we believe in empowering the people behind innovation. Through the Pedro Hermkens stipend, we support employees of campus-based companies in pursuing professional development.
The annual €1,000 stipend enables them to follow advanced courses or training to boost their skills and careers. Last year’s recipient, Josephine Stein (Citryll), completed a 10-week Harvard course in immunology.
Capsule Photonics wins Venture Challenge Winter 2024 – 2025
Each year, more than half a million people are diagnosed with esophageal cancer. Only 1 in 4 patients survive, because it is often diagnosed at a late stage. People with a higher risk of getting esophageal cancer are currently screened with endoscopy, but it misses 25% of early cancer, is time-consuming and labour-intensive. Capsule Photonics developed LightUp, a capsule endoscope that a patient can swallow without sedation.
SOTIO Biotech Expands Collaboration with Synaffix for Bispecific ADC Development
Synaffix continues to drive innovation in the ADC space. SOTIO Biotech has announced it will be exercising its option with Synaffix BV to develop two bispecific antibody-drug conjugate (ADC) programs.
Strategic Partnership between Cell4Pharma and Bio-Connect
Cell4Pharma B.V. and Bio-Connect B.V. announced a strategic partnership aimed at enhancing the distribution and commercialisation of C4P innovative in-vitro vesicular assay kits and services within the BeNeLux region.
IPA and RIBOPRO partner to advance mRNA-driven antibody discovery
IPA and RIBOPRO have announced a strategic collaboration to revolutionize therapeutic antibody discovery. By integrating RIBOPRO’s advanced mRNA and lipid nanoparticle (LNP) technologies with IPA’s AI-driven antibody discovery platform, the partnership aims to enhance antigen expression and immune responses, accelerating the development of novel therapeutics. This alliance strengthens the potential for AI-powered precision medicine by optimizing antibody discovery workflows with innovative mRNA-based immunization strategies.
Leaders in Life Sciences – #40 Douwe Breimer
In the Leaders in Life Sciences podcast, our host Henk Jan Out engages in conversations with leaders of now and soon in the life sciences sector. This episode’s guest is Douwe Breimer.
Marie Curie Building Crowned the Most Beautiful Building in Oss by jury
The Marie Curie Building at Pivot Park has been awarded the jury prize for the Most Beautiful Building in Oss, as announced during the prestigious ceremony held on Wednesday, 15 January. The expert jury highlighted the building’s strength through simplicity in design, achieving high-quality architecture with minimal means.
or call
Pivot Park – Building RK
Kloosterstraat 9
5349 AB Oss
The Netherlands
+31 (0)412 – 84 60 10
info@pivotpark.com
Pivot Park Exploitatie B.V.
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.
We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.
